Knott David M Jr Seres Therapeutics, Inc. Transaction History

Knott David M Jr

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.93 - $2.15 $279,678 - $646,569	300,730 Added 429.61%	370,730 $519,000
Q3 2023 Nov 13, 2023	SELL	$2.33 - $5.07 $932,000 - $2.03 Million	-400,000 Reduced 85.11%	70,000 $167,000
Q2 2023 Aug 11, 2023	BUY	$4.67 - $6.55 $723,850 - $1.02 Million	155,000 Added 49.21%	470,000 $2.25 Million
Q1 2023 May 11, 2023	BUY	$4.95 - $6.09 $568,755 - $699,741	114,900 Added 57.42%	315,000 $1.79 Million
Q4 2022 Feb 13, 2023	BUY	$5.09 - $9.05 $458,609 - $815,405	90,100 Added 81.91%	200,100 $1.12 Million
Q3 2022 Nov 10, 2022	BUY	$3.5 - $7.2 $385,000 - $792,000	110,000 New	110,000 $706,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.